COMMUNIQUÉS West-GlobeNewswire

ARCA biopharma Announces Second Quarter 2019 Financial Results and Provides Corporate Update

01/08/2019 - 22:30

FDA SPA Agreement for Phase 3 atrial fibrillation trial (PRECISION-AF) amended to expand patient population to include heart failure patients with preserved ejection fraction (HFpEF) PRECISION-AF clinical trial [...]

Eidos Therapeutics Reports Second Quarter 2019 Financial Results

01/08/2019 - 22:30

SAN FRANCISCO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq: EIDX), today reported its financial results for the second quarter ended June 30, 2019 and provided an update on the company’s [...]

Osmotica Pharmaceuticals plc to Provide Second Quarter 2019 Business and Financial Update on August 8, 2019

01/08/2019 - 22:30

BRIDGEWATER, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the Company will release [...]

IntelGenx to Report Second Quarter 2019 Financial Results on August 8, 2019 – Conference Call to Follow

01/08/2019 - 22:30

SAINT LAURENT, Quebec, Aug. 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its second quarter 2019 financial [...]

Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019

01/08/2019 - 22:30

Conference Call and Webcast Scheduled for Monday, August 12 at 4:30 p.m. Eastern Time YARDLEY, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, [...]

The Ensign Group Acquires California Senior Living Community

01/08/2019 - 22:26

SAN JUAN CAPISTRANO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]

The Ensign Group Acquires Arizona Hospice Agency

01/08/2019 - 22:21

SAN JUAN CAPISTRANO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]

Otonomy Reports Second Quarter 2019 Financial Results and Provides Corporate Update

01/08/2019 - 22:20

Clinical-stage programs on track with results expected from three trials in 2020 Current capital funds operations into 2021 Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE [...]

The Ensign Group Acquires Utah Skilled Nursing Facility

01/08/2019 - 22:17

SAN JUAN CAPISTRANO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]

The Ensign Group Reports Second Quarter Results

01/08/2019 - 22:15

Conference Call and Webcast scheduled for tomorrow, August 2, 2019 at 10:00 am PT MISSION VIEJO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group [...]

Fulgent Genetics Receives Laboratory Permit and Genetic Test Approval from New York State Department of Health

01/08/2019 - 22:15

TEMPLE CITY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, [...]

Globus Medical Reports Second Quarter 2019 Results

01/08/2019 - 22:15

AUDUBON, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019. Worldwide [...]

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019

01/08/2019 - 22:15

SEATTLE, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the second quarter of 2019 after market close on Tuesday, August 13, 2019. [...]

Guardant Health to Participate in Upcoming Investor Conferences

01/08/2019 - 22:07

REDWOOD CITY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/08/2019 - 22:05

BOSTON, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]

Synthorx Reports Second Quarter Financial Results

01/08/2019 - 22:05

SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial results [...]

Corcept Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update

01/08/2019 - 22:05

MENLO PARK, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial Results

01/08/2019 - 22:05

Conference Call Today at 4:30 p.m. ET / 1:30 p.m. PT BURLINGAME, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the [...]

Kura Oncology Reports Second Quarter 2019 Financial Results and Provides Corporate Update

01/08/2019 - 22:05

- Registration-directed trial of tipifarnib in HRAS mutant HNSCC ongoing – – Positive Phase 2 trial of tipifarnib in AITL and CXCL12-driven PTCL support potential paths to registration – – Additional Phase 2 data in [...]